<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Wyeth Vs. Levine: Preemption Posturing Continues</title>
	<atom:link href="http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 20:48:41 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Chloe Horozewski</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-388044</link>
		<dc:creator>Chloe Horozewski</dc:creator>
		<pubDate>Tue, 10 Feb 2009 14:08:01 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-388044</guid>
		<description>It's not wyeths fault it's the FDA's for not changing the label!</description>
		<content:encoded><![CDATA[<p>It&#8217;s not wyeths fault it&#8217;s the FDA&#8217;s for not changing the label!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Justice in MI</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-374315</link>
		<dc:creator>Justice in MI</dc:creator>
		<pubDate>Fri, 19 Sep 2008 12:47:41 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-374315</guid>
		<description>As posted in the Levine thread, I believe the NYT article missed the boat re: the issues most often at issue in preemption cases.  

Preemption, at core, is not about whether the FDA sets "optimal" guidelines.  It is about whether they had the information that would have enabled them to do so.  And, if not, what can be done, and by whom?</description>
		<content:encoded><![CDATA[<p>As posted in the Levine thread, I believe the NYT article missed the boat re: the issues most often at issue in preemption cases.  </p>
<p>Preemption, at core, is not about whether the FDA sets &#8220;optimal&#8221; guidelines.  It is about whether they had the information that would have enabled them to do so.  And, if not, what can be done, and by whom?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jaynesday</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-374309</link>
		<dc:creator>Jaynesday</dc:creator>
		<pubDate>Fri, 19 Sep 2008 12:22:57 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-374309</guid>
		<description>And unfortunately the FDA is handing out trump cards.</description>
		<content:encoded><![CDATA[<p>And unfortunately the FDA is handing out trump cards.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jaynesday</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-374306</link>
		<dc:creator>Jaynesday</dc:creator>
		<pubDate>Fri, 19 Sep 2008 10:42:32 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-374306</guid>
		<description>Nathan,
I agree with laurie - in different words -
Drug and device companies have too many incentives (pre and post)along with too much ability to hide critical information from the FDA. The only incentive against hiding critical information is litigation. 
Honesty is the best policy but too often greed is the trump card.</description>
		<content:encoded><![CDATA[<p>Nathan,<br />
I agree with laurie - in different words -<br />
Drug and device companies have too many incentives (pre and post)along with too much ability to hide critical information from the FDA. The only incentive against hiding critical information is litigation.<br />
Honesty is the best policy but too often greed is the trump card.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: laurie</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-374305</link>
		<dc:creator>laurie</dc:creator>
		<pubDate>Fri, 19 Sep 2008 10:28:53 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-374305</guid>
		<description>"“No drug is without risks. The F.D.A. balances the risks of a drug against its benefits to maximize the availability of beneficial treatments"

This statement should be true, but the recent lack of disclosure to the FDA of known risks of certain drugs makes this a moot point.

Until the FDA sets in place a system of obtaining and evaluating ALL the information that a drug company has about a drug, then they cannot be considered the final word on a drugs safety.

We are far from that situation.</description>
		<content:encoded><![CDATA[<p>&#8220;“No drug is without risks. The F.D.A. balances the risks of a drug against its benefits to maximize the availability of beneficial treatments&#8221;</p>
<p>This statement should be true, but the recent lack of disclosure to the FDA of known risks of certain drugs makes this a moot point.</p>
<p>Until the FDA sets in place a system of obtaining and evaluating ALL the information that a drug company has about a drug, then they cannot be considered the final word on a drugs safety.</p>
<p>We are far from that situation.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Nathan</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-374304</link>
		<dc:creator>Nathan</dc:creator>
		<pubDate>Fri, 19 Sep 2008 10:19:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-374304</guid>
		<description>There was a nice article in the NYTimes this morning about the Levine case.
http://www.nytimes.com/2008/09/19/us/19scotus.html?pagewanted=1&#38;_r=1&#38;hp&#38;adxnnlx=1221819274-t95zI9T5%20PzloMXpxbRB/A

I thought they did a great job of distilling the debate down to two sentences: "Do the F.D.A. and other federal regulators set minimum safety standards that states are free to augment? Or do they make judgments about the optimal balance between risks and benefits that states must follow?"

Obviously I lean towards the latter.  They also quoted the dissenting opinion from the Vermont supream court.  Again, an interesting statement that I agree with: "No drug is without risks. The F.D.A. balances the risks of a drug against its benefits to maximize the availability of beneficial treatments.  A jury does not engage in a measured and multifaceted policy analysis. Rather, a jury views the safety of the drug through the lens of a single patient who has already been catastrophically injured.”</description>
		<content:encoded><![CDATA[<p>There was a nice article in the NYTimes this morning about the Levine case.<br />
<a href="http://www.nytimes.com/2008/09/19/us/19scotus.html?pagewanted=1&amp;_r=1&amp;hp&amp;adxnnlx=1221819274-t95zI9T5%20PzloMXpxbRB/A" rel="nofollow">http://www.nytimes.com/2008/09/19/us/19scotus.html?pagewanted=1&amp;_r=1&amp;hp&amp;adxnnlx=1221819274-t95zI9T5%20PzloMXpxbRB/A</a></p>
<p>I thought they did a great job of distilling the debate down to two sentences: &#8220;Do the F.D.A. and other federal regulators set minimum safety standards that states are free to augment? Or do they make judgments about the optimal balance between risks and benefits that states must follow?&#8221;</p>
<p>Obviously I lean towards the latter.  They also quoted the dissenting opinion from the Vermont supream court.  Again, an interesting statement that I agree with: &#8220;No drug is without risks. The F.D.A. balances the risks of a drug against its benefits to maximize the availability of beneficial treatments.  A jury does not engage in a measured and multifaceted policy analysis. Rather, a jury views the safety of the drug through the lens of a single patient who has already been catastrophically injured.”</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: jooe</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-374124</link>
		<dc:creator>jooe</dc:creator>
		<pubDate>Thu, 18 Sep 2008 11:10:48 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-374124</guid>
		<description>You all are missing the point. You are arguing the facts of the trial, which Wyeth was already found to be at fault and ordered to pay Miss Leving $6 million dollars. The issue at hand is pre emption. Does the FDA stamp of approval protect all pharmaceutical drugs from lawsuits. Thus making humans guinea pigs for the pharmaceutical industry. There will be no reason to spend money on lab rats when they can just run their tests on us humans, and make us pay them to take their medicine. Then when we are injured, have the US taxpayers pay our medical/disability expenses for the rest of our lives under Medicaid or Disability. Look at all of the Vioxx users that have cost the taxpayers billions of dollars in Medicare/Disability, all because Merck lied and hid facts about their dangerous drug. As a US taxpayer, I don't believe I should have to pay for Merck's liability.</description>
		<content:encoded><![CDATA[<p>You all are missing the point. You are arguing the facts of the trial, which Wyeth was already found to be at fault and ordered to pay Miss Leving $6 million dollars. The issue at hand is pre emption. Does the FDA stamp of approval protect all pharmaceutical drugs from lawsuits. Thus making humans guinea pigs for the pharmaceutical industry. There will be no reason to spend money on lab rats when they can just run their tests on us humans, and make us pay them to take their medicine. Then when we are injured, have the US taxpayers pay our medical/disability expenses for the rest of our lives under Medicaid or Disability. Look at all of the Vioxx users that have cost the taxpayers billions of dollars in Medicare/Disability, all because Merck lied and hid facts about their dangerous drug. As a US taxpayer, I don&#8217;t believe I should have to pay for Merck&#8217;s liability.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Justice in MI</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-373983</link>
		<dc:creator>Justice in MI</dc:creator>
		<pubDate>Wed, 17 Sep 2008 21:19:53 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-373983</guid>
		<description>I am not for holding a company accountable if there was no reasonable way they could have acted that might have made a difference.  Levine is arguing that there _were_ such ways - communications to HCPs and a CBE.  Whether that argument makes sense, and Wyeth should be liable for not so acting,  is the crux of the case.

Re: the FDA, if the situation is as bad as some posters have recently described, they are grim indeed.  But compensating Diana Levine is not the answer to cleaning house there either.  That said, Salmon makes interesting points re: citizens' petitions, etc..  If one followed Catherine Sharkey's viewpoint, FDA would have to show (to a judge) - and not simply assert - that it reviewed whatever relevant risk in an appropriate way in order for preemption to kick in.

Sidelight - the one place the reply brief veers off point is a footnote in which NEJM's analysis of the fen-phen (Wyeth's Pondimin/Redux) case is rejected.</description>
		<content:encoded><![CDATA[<p>I am not for holding a company accountable if there was no reasonable way they could have acted that might have made a difference.  Levine is arguing that there _were_ such ways - communications to HCPs and a CBE.  Whether that argument makes sense, and Wyeth should be liable for not so acting,  is the crux of the case.</p>
<p>Re: the FDA, if the situation is as bad as some posters have recently described, they are grim indeed.  But compensating Diana Levine is not the answer to cleaning house there either.  That said, Salmon makes interesting points re: citizens&#8217; petitions, etc..  If one followed Catherine Sharkey&#8217;s viewpoint, FDA would have to show (to a judge) - and not simply assert - that it reviewed whatever relevant risk in an appropriate way in order for preemption to kick in.</p>
<p>Sidelight - the one place the reply brief veers off point is a footnote in which NEJM&#8217;s analysis of the fen-phen (Wyeth&#8217;s Pondimin/Redux) case is rejected.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-373980</link>
		<dc:creator>Chris</dc:creator>
		<pubDate>Wed, 17 Sep 2008 20:58:59 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-373980</guid>
		<description>Why do you say it was no one's fault given that the drug was inadvertently (and thus inappropriately) administered into an artery rather than a vein?</description>
		<content:encoded><![CDATA[<p>Why do you say it was no one&#8217;s fault given that the drug was inadvertently (and thus inappropriately) administered into an artery rather than a vein?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Nathan</title>
		<link>http://www.pharmalot.com/2008/09/wyeth-vs-levine-preemption-posturing-continues/#comment-373973</link>
		<dc:creator>Nathan</dc:creator>
		<pubDate>Wed, 17 Sep 2008 20:34:33 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=15659#comment-373973</guid>
		<description>David Y,
Are you suggesting a "bad luck" pot of money?  That's absurd!  Who would fund it?  Who determines who gets the money?

I agree that this was really no one's fault.  But sometimes sh*t happens in life and we learn to deal with the hand that life gives us -- even if we don't like it.  Bad things happen all the time that aren't really anyone's fault.  Do they get compensated?</description>
		<content:encoded><![CDATA[<p>David Y,<br />
Are you suggesting a &#8220;bad luck&#8221; pot of money?  That&#8217;s absurd!  Who would fund it?  Who determines who gets the money?</p>
<p>I agree that this was really no one&#8217;s fault.  But sometimes sh*t happens in life and we learn to deal with the hand that life gives us &#8212; even if we don&#8217;t like it.  Bad things happen all the time that aren&#8217;t really anyone&#8217;s fault.  Do they get compensated?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.161 seconds -->

